Microbia Announces Second Collaboration Agreement with Ranbaxy Laboratories
News Nov 02, 2005
Microbia, Inc. have announced that its Precision Engineering™ business unit has entered into a research collaboration with Ranbaxy Laboratories to lower the cost of a biomanufacturing process under development by Ranbaxy.
The goal is to achieve a greater than 100 percent productivity improvement in the precommercial biomanufacturing of an undisclosed pharmaceutical product.
Microbia will undertake strain engineering and laboratory-scale testing. Ranbaxy assumes responsibility for optimizing processes and validating product specification acceptability.
Under the agreement, Ranbaxy will fund Microbia's research and development and will make payments based on the achievement of development milestones. Financial terms were not disclosed.
This is the second agreement between the two companies, following a successful collaboration to apply Precision Engineering™ to generate higher yields in a Ranbaxy biomanufacturing process for a statin.
Ranbaxy has since advanced the improved strain into commercial manufacturing. The two companies have collaborated to improve biomanufacturing processes since February 2003.
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu VaccineNews
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, announces that Innovate UK, the UK’s innovation agency, has awarded the company a grant of £979,318 to progress its universal flu vaccine programme through preclinical development.READ MORE
Porvair Sciences Makes Strategic Appointment for US Microplate BusinessNews
Porvair Sciences and J.G. Finneran Associates are pleased to announce the appointment of Bob Brino as OEM Business Development Manager for their microplate and sample prep product lines.READ MORE
Comments | 0 ADD COMMENT
World Congress on Bio-organic and Medicinal Chemistry
Nov 12 - Nov 13, 2018